Intera’s portfolio consists of Intera 3000 Hepatic Artery Infusion Pump, which is used to administer chemotherapy in liver ...

Boston Scientific has signed a deal to acquire the maker of a chemotherapy infusion pump aimed at treating certain inoperable ...

Boston Scientific has signed a definitive agreement to acquire a Boston-based infusion pump maker Intera Oncology. Intera’s main asset is its hepatic artery infusion (HAI) therapy device ...

Boston Scientific (NYSE:BSX) announced today that it agreed to acquire infusion pump maker Intera Oncology for an undisclosed ...

Boston Scientific Corporation BSX has entered into a definitive agreement to acquire Intera Oncology Inc., a Boston-based life science company. The acquisition expands the company’s interventional ...

Beyond her expert knowledge and dedication in oncology care at Smilow Breast Center, in infusion and with her history as a ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Intera Oncology, a privately held medical device ...

Intera makes a pump and a chemotherapy drug to treat liver tumors. Boston Scientific sees the purchase as a way to provide ...

Boston Scientific Corp. (BSX) announced Monday it has entered into a definitive agreement to acquire Intera Oncology Inc., a ...

Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Intera Oncology Inc. Boston ...

Zanidatamab is the first agent approved specifically for advanced, HER2-positive second-line biliary tract cancer.